UBS analyst Karl Keirstead maintains DocuSign (NASDAQ:DOCU) with a Neutral and lowers the price target from $65 to $52.
UBS Maintains Neutral on DocuSign, Lowers Price Target to $52
UBS analyst Karl Keirstead maintains DocuSign (NASDAQ:DOCU) with a Neutral and lowers the price target from $65 to $52.
Related Posts
‘Taylor Swift Box Office: Theater Owners Predict Record $100M Opening For Eras Tour Concert Pic’ – Hollywood Reporter
https://www.hollywoodreporter.com/movies/movie-news/taylor-swift-eras-tour-movie-1235581725/
With the summer season over, cinemas are counting on 'Taylor Swift: The Eras Tour' film to be a formidable
Deutsche Bank Maintains Buy on Dollar Gen, Lowers Price Target to $265
Deutsche Bank analyst Krisztina Katai maintains Dollar Gen (NYSE:DG) with a Buy and lowers the price target from $266 to $265.
Honeywell Wins T55 Engine Contract From The US Army In Support Of South Korea
Honeywell (NASDAQ:HON) today announced it has received an order for 41 T55-GA-714A engines to support South Korea's procurement of new CH-47F aircraft as part of an effort to replace its